Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview

@article{Drayer1986PharmacodynamicAP,
  title={Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview},
  author={Dennis E. Drayer},
  journal={Clinical Pharmacology \& Therapeutics},
  year={1986},
  volume={40}
}
  • D. Drayer
  • Published 1 August 1986
  • Chemistry, Medicine
  • Clinical Pharmacology & Therapeutics
Clinical Pharmacology and Therapeutics (1986) 40, 125–133; doi:10.1038/clpt.1986.150 

Topics from this paper

Bias in pharmacokinetics and clinical pharmacology
Clinical Pharmacology and Therapeutics (1987) 42, 361–363; doi:10.1038/clpt.1987.163
Stereoisomerism and drug nomenclature
  • J. Gal
  • Chemistry, Medicine
  • Clinical pharmacology and therapeutics
  • 1988
Clinical Pharmacology and Therapeutics (1988) 44, 251–253; doi:10.1038/clpt.1988.146
Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
Review providing a comprehensive, rather than exhaustive, appraisal of enantioselective drug action and pharmacokinetic
Enantiomer specific pharmacokinetics.
TLDR
To emphasise the potential benefits of studying enantiospecific pharmacokinetics, that is, kinetics based on the measurement of the time-course of separate isomers rather than of the total, racemic drug mixture. Expand
ENANTIOSELECTIVE DRUG ANALYSIS: PROBLEMS AND RESOLUTIONS
  • R. Nation
  • Chemistry, Medicine
  • Clinical and experimental pharmacology & physiology
  • 1989
TLDR
This work has shown that the enantiomers of a chiral drug can differ pharmacokinetically and/or pharmacodynamically, and there is considerable interest in methods for the resolution and quantification of enantiomer methods. Expand
Implications of the Neglect of Stereochemistry in Pharmacokinetics and Clinical Pharmacology
An outline is given of the implications of stereoselectivity in biological action and the use of racemic fixed-ratio combinations in pharmacology and pharmacotherapeutics. Pitfalls of the neglect ofExpand
Clinical Pharmacokinetics 1990
These developments in analytical techniques, evaluation of disease state effects on pharmacokinetics and pharmacodynamics, enhancements in data analysis and technological advances which allow usExpand
RACEMATES OR ENANTIOMERS: REGULATORY APPROACHES
  • D. Birkett
  • Chemistry, Medicine
  • Clinical and experimental pharmacology & physiology
  • 1989
TLDR
The development of chemical methods to separate and analyse drug enantiomers has led to a growing understanding of their biological properties and a regulatory dilemma as to whether only enantiomerically pure drugs should be marketed. Expand
New Clinical Pharmacology Concepts in Pain Management
TLDR
The scientific foundation of clinical pharmacology has advanced remarkably in the last few decades, particularly in anesthesiology and pain management, and modern pharmacokinetic- pharmacodynamic modeling techniques have enabled physicians to predict drug response with a quantitative exactness that was unimaginable in the early days of modern medicine. Expand
Enantiomeric separation of drugs and related compounds based on their interaction with α1-acid glycoprotein
Traditionally, the separation of enantiomers involves the preparation of diastereomeric derivatives followed by separation on an non-chiral column. This article will focus on the use of the plasmaExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 70 REFERENCES
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
TLDR
Isomers of the monoamine oxidase inhibitor tranylcypromine were administered separately to 15 hospitalized parkinsonian patients and differences between the pharmacokinetics were substantial, (-)tranylcy Promine being excreted much faster. Expand
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.
TLDR
Following oral administration the same concentration of plasma verapamil consisting of a two to three times smaller proportion of the more potent (-)-isomer appeared to be less potent than that following i.v. administration with regard to the negative dromotropic effects on the AV conduction. Expand
Pharmacokinetics of warfarin enantiomers: A search for intrasubject correlations
TLDR
The Maintenance dose of racemic warfarin required by an individual patient may be a useful predictor of the maintenance dose of S(−)‐warfarin which will produce a comparable degree of anticoagulation, and no such predictability is evident with respect to R(+)‐warFarin. Expand
Analgesic and other effects of the d‐ and l‐isomers of pentazocine
TLDR
It appears that analgesia resides principally in the l‐isomer, and relative potency for l‐pentazocine based on effects measured up to 255 minutes was found to be 0.35 to 0.40. Expand
Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
TLDR
It is demonstrated that N-dealkylation in dogs and arylhydroxylation with greater metabolism with (S)-(+)-DP in rats are stereoselective metabolic pathways, thus illustrating species differences in the stereOSElective metabolism of DP. Expand
Comparative pharmacology of the ketamine isomers. Studies in volunteers.
TLDR
It is concluded that the more potent S(+) isomer of ketamine was associated with a more rapid recovery of psychomotor skills than the currently used racemic mixture. Expand
A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.
In a placebo controlled open study in six healthy male volunteers (+)-sotalol in the dose range 0.125 mg kg-1-2.0 mg kg-1 intravenously, was found to have little or no beta-adrenoceptor blockingExpand
High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate.
TLDR
Using d- and l-oxazepam hemisuccinate (RV 1208 and RV 1210), the stereospecificity of binding of benzodiazepines to human serum albumin was investigated and it was found that no ligands other than tryptophan exhibit this high degree of stereo-spatial binding to HSA. Expand
Serum binding of tocainide and its enantiomers in human subjects.
TLDR
Binding appeared independent of serum tocainide concentration within the therapeutic range of 4 to 12 micrograms/ml, and the binding of the S-(+) enantiomer was slightly but statistically significantly greater than that of the R-(-) isomer. Expand
The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies
TLDR
S (−) phenprocoumon is a more potent anticoagulant than R (+) phen Procoumon and that the pharmacokinetic d~fferences between the enantiomers are due mainly to differences in their distribution. Expand
...
1
2
3
4
5
...